The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:** Merck & Co Inc said on Tuesday it will proceed with its planned $8.4 billion purchase of Cubist Pharmaceuticals Inc and still expects the deal to boost its long-term earnings, despite a court ruling that could speed the arrival of generic forms of Cubist's top-selling product.
Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in other acute care settings. Shares of CBST fell by 4.72% or $-4.75/share to $95.85. In the past year, the shares have traded as low as $58.50 and as high as $101.82. On average, 1116560 shares of CBST exchange hands on a given day and today's volume is recorded at 25285622.
Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. Shares of MRK fell by 3.02% or $-1.87/share to $60.01. In the past year, the shares have traded as low as $47.61 and as high as $62.20. On average, 10653600 shares of MRK exchange hands on a given day and today's volume is recorded at 18635514.
Source
